Response to febuxostat differed based on hyperuricemia subtype in older patients with gout, with the combined subtype linked to the lowest rates of SU target achievement.

Please provide your email address to receive an email when new articles are posted on . According to survey results presented in a press release from Ironwood Pharmaceuticals Inc., 51% of physicians ...

BARCELONA, Spain — A “treat-to-target” approach for gout was associated with a modest but significant reduction in the risk for major cardiovascular (CV) events (MACEs) when compared to a ...

Study findings may help to resolve a controversy between rheumatology societies and the American College of Physicians regarding gout management recommendations. Achievement of target serum urate ...

Please provide your email address to receive an email when new articles are posted on . A treat to target serum urate level may have a beneficial effect on reducing fracture risk in patients with gout ...

Optimizing urate-lowering therapy to achieve target serum urate levels may not harm, and may benefit, patients with gout and CKD. Despite clinician concerns, treating patients with gout and stage 3 ...

CHICAGO -- More intense treatment of gout with a treat-to-target strategy can reduce patients' risk for death, a Spanish researcher told a press conference Monday at the American College of ...